Search Results - "Fargion ‡, Silvia"
-
1
Representations of parenting and the neo-liberal discourse: parents' and professionals' views on child-rearing practices in Italy
Published in Journal of family studies (02-01-2023)“…With neoliberal ideologies having inspired social policies for families across the world, the discourse on childrearing as the sole responsibility of…”
Get full text
Journal Article -
2
Nonalcoholic fatty liver disease and vascular disease:State-of-the-art
Published in World journal of gastroenterology : WJG (07-10-2014)“…Nonalcoholic fatty liver disease(NAFLD), the most common of chronic liver disease in Western Country, is closely related to insulin resistance and oxidative…”
Get full text
Journal Article -
3
Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target
Published in Journal of hepatology (01-10-2011)“…Summary The dysmetabolic iron overload syndrome (DIOS) is now a frequent finding in the general population, as is detected in about one third of patients with…”
Get full text
Journal Article -
4
miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis
Published in International journal of molecular sciences (10-12-2018)“…Nonalcoholic fatty liver disease (NAFLD) defines a wide pathological spectrum ranging from simple steatosis to nonalcoholic steatohepatitis (NASH) which may…”
Get full text
Journal Article -
5
Role of Serum Uric Acid and Ferritin in the Development and Progression of NAFLD
Published in International Journal of Molecular Sciences (12-04-2016)“…Nonalcoholic fatty liver disease (NAFLD), tightly linked to the metabolic syndrome (MS), has emerged as a leading cause of chronic liver disease worldwide…”
Get full text
Journal Article Book Review -
6
Statin use and non-alcoholic steatohepatitis in at risk individuals
Published in Journal of hepatology (01-09-2015)“…Graphical abstract…”
Get full text
Journal Article -
7
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent
Published in Gastroenterology (New York, N.Y. 1943) (01-05-2016)“…Background & Aims Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver damage and is characterized by steatosis. Genetic factors increase risk…”
Get full text
Journal Article -
8
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
Published in Hepatology (Baltimore, Md.) (01-02-2015)“…Excess hepatic storage of triglycerides is considered a benign condition, but nonalcoholic steatohepatitis (NASH) may progress to fibrosis and promote…”
Get full text
Journal Article -
9
Nutrients, Genetic Factors, and Their Interaction in Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease
Published in International journal of molecular sciences (19-11-2020)“…Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in Western countries and expose patients to increased risk of hepatic and…”
Get full text
Journal Article -
10
I148M patatin‐like phospholipase domain‐containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease
Published in Hepatology (Baltimore, Md.) (01-10-2010)“…Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease in children. Genetic variability, which is a main player in…”
Get full text
Journal Article -
11
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals
Published in Scientific reports (03-07-2017)“…Nonalcoholic fatty liver disease (NAFLD) represents an emerging cause of hepatocellular carcinoma (HCC), especially in non-cirrhotic individuals. The rs641738…”
Get full text
Journal Article -
12
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
Published in Scientific reports (06-03-2019)“…Nonalcoholic fatty liver disease (NAFLD) is a rising cause of hepatocellular carcinoma (HCC). We examined whether inherited pathogenic variants in candidate…”
Get full text
Journal Article -
13
PD-1/PD-L1 Immuno-Mediated Therapy in NAFLD: Advantages and Obstacles in the Treatment of Advanced Disease
Published in International journal of molecular sciences (28-02-2022)“…Non-alcoholic fatty liver disease (NAFLD) is characterized by an enhanced activation of the immune system, which predispose the evolution to nonalcoholic…”
Get full text
Journal Article -
14
Patatin‐Like phospholipase domain‐containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C
Published in Hepatology (Baltimore, Md.) (01-03-2011)“…Steatosis has been reported to negatively influence the natural history of chronic hepatitis C (CHC), but controversy remains over its causal role due to the…”
Get full text
Journal Article -
15
Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease
Published in PloS one (20-09-2016)“…The clinical determinants of fibrosis progression in nonalcoholic fatty liver disease (NAFLD) are still under definition. To assess the clinical determinants…”
Get full text
Journal Article -
16
Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up
Published in Atherosclerosis (01-03-2016)“…Abstract Background and aim Non-alcoholic fatty liver disease (NAFLD) is associated not only with liver related morbidity and mortality but also with an…”
Get full text
Journal Article -
17
A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia
Published in World journal of gastroenterology : WJG (21-03-2014)“…AIM:To compare iron depletion to lifestyle changes alone in patients with severe nonalcoholic fatty liver disease(NAFLD)and hyperferritinemia,a frequent…”
Get full text
Journal Article -
18
Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease
Published in Clinical science (1979) (01-06-2017)“…In patients with non-alcoholic fatty liver disease (NAFLD), insulin resistance (IR) associates with fibrosis progression independently of the hepatic…”
Get more information
Journal Article -
19
The rs2294918 E434K variant modulates patatin‐like phospholipase domain‐containing 3 expression and liver damage
Published in Hepatology (Baltimore, Md.) (01-03-2016)“…The patatin‐like phosholipase domain‐containing 3 (PNPLA3) rs738409 polymorphism (I148M) is a major determinant of hepatic fat and predisposes to the full…”
Get full text
Journal Article -
20
MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease
Published in Journal of hepatology (01-03-2016)“…Background & Aim Homozygosity for a common non-coding rs4374383 G>A polymorphism in MERTK (myeloid-epithelial-reproductive tyrosine kinase) has been associated…”
Get full text
Journal Article